Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2019-08-28
Buyer: Kristiansand kommune
Country: NO
Contract type: Services
Procedure: Contract award without prior publication
CPV classification: 73300000
Estimated value: 5000000 NOK

Technical requirements: Services are being tested out in Agder, including research within telemedicine/remote medical follow-up. The aim of the testing is:
'Remote follow-up/telemedicine is integrated in patients' health service (municipalities/GPs and hospitals) in Agder by 2022, in such a way that it is beneficial'.
Testing is ongoing through the Telma project in the period 2016-2019, and this overlaps with a project managed by the National Welfare Technology Programme, NVP Remote Follow-Up (2018-2021). This is a test project initiated by the Directorate of Health, on behalf of the Ministry of Health and Care Services. The project must submit a report with national recommendations, based on experiences from the testing in the project period. The participating municipalities in the project are Bodø, Eid, Oslo with 4 districts, Ullensaker/Gjerdrum, Larvik and Kristiansand with collaboration municipalities.
Kristiansand Municipality, in collaboration with Arendal, Grimstad and Farsund Municipalities, Sørlandet Hospital and GPs, is one of 6 national projects that are part of the Directorate of Health's national welfare technology programme. The project period is 2018-2021 and the aim is to test out remote medical follow-up for chronically sick persons. Kristiansand Municipality is part of a research and development contract (R&D contract) with Siemens Healthineers, which builds on an ongoing collaboration on service and technology development in another parallel ongoing project, TELMA, financed by NRF.
The intention of the contract is the further development of the platform used in Telma, in order to obtain new knowledge and further develop the current systems for remote medical follow-up in the municipalities.
The Telma project has sketched a large development potential for the technology, and the project will particularly focus on development connected to interaction between the actors, responsiveness and user friendliness of the systems, reporting/monitoring, artificial intelligence and machine learning, and the potential for 'Bring Your Own Device'.
Experiences from the project will help form the basis for the national reports that will be written after the project has ended. These reports will be available to the public on the Directorate of Health's website.
In 2019 Telma is still in the project period with testing and the inclusion of patients for the project. The technology and collaboration with existing suppliers is decisive for the further development and results of project.
When NVP Remote Follow-Up now starts, with the inclusion of the same patient groups, but with another research design, it will be decisive that the municipalities in Agder do not implement new and different technology. The arguments for this are as follows:
The technology is still being developed and tested. There is a need for supplementary equipment, and secure technical and practical logistical systems.
A double set of equipment for testing at service providers will be experienced as very inexpedient, and would, therefore reduce participation and testing.
The re-use of the existing structure for testing and further development of technological systems will increase the chances of achieving the project'a goals.
It is possible to compare results for patients, relatives and employees across the 2 projects with uncertainty factors connected to different or new technological equipment.


Winner: Siemens Healthcare AS
Award value: 5000000